Clinical Trials Logo

Heat Stroke clinical trials

View clinical trials related to Heat Stroke.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05091515 Completed - Overheating Clinical Trials

Thermoregulatory Reactions of Medical Workers Who Use Personal Protective Equipment From Biological Hazards

Start date: March 29, 2021
Phase:
Study type: Observational

This research will provide data on thermal condition, functional status and working conditions of medical workers who use personal protective equipment from biological hazards. Acquired data will be used to define acceptable period of use for these protective costumes.

NCT ID: NCT03600376 Completed - Clinical trials for Exertional Heat Stroke

Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS

Start date: August 19, 2018
Phase: Phase 3
Study type: Interventional

A double-blind, parallel study of Ryanodex for the adjuvant treatment of exertional heat stroke (EHS) compared to current Standard of Care (SOC) for EHS.

NCT ID: NCT03513315 Completed - Heat Clinical Trials

Heat Emergency Awareness and Treatment (HEAT)

HEAT
Start date: November 30, 2016
Phase: N/A
Study type: Interventional

Investigators propose an intervention trial of a comprehensive education and treatment bundle designed to reduce morbidity and mortality associated with heat-related illness for low resource settings. Two set of interventions will be developed each for emergency department and for community/home. These interventions will be developed by an internal expert group and will be customized and implemented at the home and emergency department (ED) levels, will include evidence-based educational training guidelines for ED health providers as well as educational messages targeting home and community in Karachi, Pakistan.

NCT ID: NCT02513095 Completed - Heat Stroke Clinical Trials

Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)

Start date: September 2015
Phase: Phase 2
Study type: Interventional

Study EGL-4104-C-1502 is a phase 2, single-site, open-label, randomized, 2-arm parallel study of Ryanodex for the adjuvant treatment of exertional heat stroke (EHS) administered intravenously (IV), to current standard of care (SOC). SOC for the treatment of EHS is defined as effective body cooling, which should be implemented as quickly as available after diagnosis of exertional heat stroke.

NCT ID: NCT01694290 Completed - Clinical trials for Heat Stroke, Heat Exhaustion

Chemical Ice Packs for Cooling Hyperthermic Patients

Start date: August 2012
Phase: N/A
Study type: Interventional

A common tool to cool people in the pre-hospital setting is the chemical ice pack. These are used by athletic trainers, EMS personnel, ER staff, and people in the prehosoital setting. The ability of these to cool a person has never been quantified, the efficiency and extent of cooling, as well as location of placement of ice packs is purely anecdotal. The purpose of this study is to determine whether strategically placed chemical ice packs will provide benefit to individuals subjected to heat stress.

NCT ID: NCT01290159 Completed - Healthy Clinical Trials

The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat

Start date: May 2011
Phase: N/A
Study type: Observational

Today, the level of tolerance to heat is based on physiological strain indices, with no correlates to any relevant biomarker. We hypothesize that oxidative stress (OS) and the formation of reactive oxygen and nitrogen species (ROS, RNS), which are part of the underling pathophysiology related to hyperthermia, can be used to identify tolerance/intolerance to heat. The aim of the present project is to develop a simple assay, based on specific designed sensitive biomarkers of OS that can be detected in a small blood sample, and to possibly correlate each individual's state of tolerance to heat to the level of OS. These biomarkers specially designed and synthesized to form a novel probe (not present as such in biological organs). The method will be based on the incubation of the suggested biomarkers with the patient's blood sample and the measurement of the level and type of oxidative alteration of the markers. For this goal, post heat stroke patients, with different levels of tolerance to heat and subjects during a process of acclimation to heat will be studied. Such a method will add to our ability to better determine the level of tolerance to heat and not rely only on the measurements of temperature and heart rate during an exercise-heat stress.